- The addition of statements concerning discontinuation of prophylaxis against specific OIs when the CD4+ T-lymphocyte count increases in response to HAART
- New recommendations regarding human herpesvirus type 8 and hepatitis C virus
- New recommendations concerning injection drug users
- New recommendations about short-course chemoprophylaxis against tuberculosis in HIV-infected persons with positive tuberculin skin tests
- Changes in secondary prophylaxis (chronic maintenance therapy) recommended to prevent the recurrence of Mycobacterium avium complex and cytomegalovirus disease
- Caution against using fluconazole during pregnancy
- Statements concerning the use of varicella and rotavirus vaccines among HIV-infected infants
|
|